Latest Zofran Child Birth Defect Lawsuits
17 June 2015

Zofran Attorneys Filing Birth Defect Lawsuits In Arkansas

Zofran is a drug that was given permission for use in the US by the Food and Drug Administration (FDA) in 1991. Zofran’s main purpose is for use by cancer patients experiencing nausea and vomiting caused by their chemo and radiation therapy treatment. Also, post-operative patients in need of nausea relief can take Zofran as well. GlaxoSmithKline, the creators of Zofran further went to promote Zofran as an off-label drug for alleviating persistent nausea and vomiting associated with morning sickness in pregnant women. The FDA never gave permission for Zofran to be used by pregnant women.

A 2012 CDC and Sloan Epidemiology Center study found that pregnant women who took Zofran in the first 12 weeks of pregnancy doubled the likelihood of a child being born with a cleft palate. In May, 2015 an Arkansas family filed a case against GSK stating that their drug, taken by the mom for morning sickness, led to their son being born with a cleft lip. The complainant stated that she was prescribed Zofran in order to treat morning sickness in the early stages of her pregnancy. The only reason why the complainant used Zofran was because the drug was marketed as a safe drug during pregnancy. But that was not the case as she gave birth to her son who was diagnosed with a partial cleft lip. Read more about this Arkansas lawsuit here.

Birth Defects Information In Arkansas

It is estimated that each year in Arkansas, approximately 1,300 babies are diagnosed with a birth defect and more than 100 babies will die because of them. The CDC has accounted that for every 33 babies in the country, one is likely to have a birth deformity. Arkansas population is fixed at 2,966,369 since 2014. From that population figure these are the cities that have the most people living in them:

  • Little Rock- 197,706 population
  • Fort Smith- 87,351 population
  • Fayetteville- 80,621 population
  • Springdale- 76,565 population
  • Jonesboro- 72,210 population

From the time Zofran made it onto the US market in 1991, it swiftly went on to be the anti-nausea drug of choice in America. By 2005 it is said that Zofran had dominated 99% of the market. Making use of this data our Zofran attorneys have assessed the potential number of births that have been negatively affected by the mother taking Zofran in the early stages of her baby’s development. In addition, average risk ratios recognized in clinical studies performed were also accounted for in the assessment. We assess that roughly 1,490 infant births in Arkansas ended with a birth abnormality due to the baby being exposed to Zofran in the first trimester.

Zofran Affiliated Orofacial Cleft & Congenital Heart Abnormalities In Arkansas

Utilizing the Arkansas population of 2,966,369, we were able to calculate that a probable 278 births were a type of orofacial cleft and 1,212 births had congenital heart abnormalities. For Arkansas city by city orofacial cleft and congenital heart abnormalities affiliated with Zofran intake, our calculations show the following:

  • Little Rock- 143 birth deformities with almost 19 orofacial cleft, and 124 congenital heart abnormalities
  • Fort Smith- 91 birth deformities with almost 8 orofacial cleft, and 83 congenital heart abnormalities
  • Fayetteville- 88 birth deformities with almost 8 orofacial cleft, and 80 congenital heart abnormalities
  • Springdale- 86 birth deformities with almost 7 orofacial cleft, and 79 congenital heart abnormalities
  • Jonesboro- 84 birth deformities with almost 7 orofacial cleft, and 77 congenital heart abnormalities

Various Types Of Birth Defects & Adverse Effects Of Using Zofran

Lawsuits that have been filed have seen complainants state that Zofran, which was taken as an anti-nausea medication during pregnancy, led to the child being born with birth defects. These charges are based on studies conducted by medical communities around the world that have seen that Zofran has the propensity to cause certain defects when taken in the first three months of pregnancy. Nonetheless, GSK does not acknowledge that these defects are caused by Zofran itself.

Some of the noted adverse effects caused by Zofran on an unborn baby are:

  • Hole in the heart
  • Kidney Malformations
  • Cleft palate/ Cleft lip
  • Facial Dysmorphia
  • Syndactyly
  • Low set ears
  • Congenital Talipes Equinovarus (CTEV)

Using To Learn About Filing A Case is supported by various law firms located in different parts of the country. The aim of the website is to provide regular and up to date news about the Zofran suit. Even though our legal team is not licensed to practice law in the state of Arkansas, we have the authority to practice law in Delaware. We have offices in Delaware State too which enables us to effectively and efficiently handle your lawsuit if it is filed there. GSK headquarters are also in Delaware. To contact us at our Delaware offices click here.

We have already received multiple inquiries from parents from Arkansas who trust their child was born with birth defects because of Zofran that was taken when the mother was pregnant. Your case can be filed in Delaware or depending on your case it may even be better suited for your family to file a case in Arkansas. If Arkansas is an advisable place to file, then we will make sure your case is filed using our recommended Arkansas local counsel.

We are here to speak with you at any time of the day and are waiting to help guide you through this time. Learn more about our Zofran team here.

Where To Locate Cleft Palate and Congenital Heart Abnormalities Information In Arkansas

Call Now Button